HUM Humana (HUM) Q3 FY25 earnings call
Humana delivered a solid third quarter, with medical cost trends and full-year adjusted EPS outlook remaining consistent with expectations. The company is focused on maximizing customer lifetime value through improved retention and strategic growth, with early AEP results showing favorable sales mix and reduced plan-to-plan movement. Operational improvements and capital optimization efforts are underway to support long-term profitability and clinical excellence.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
HUM operating KPIs by quarter
| KPI | Dec 2024 Q4 FY24 | Mar 2025 Q1 FY25 | Jun 2025 Q2 FY25 | Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|---|---|---|
| Employees | 65KI also just want to thank the 65,000 associates that we have who are serving our members and patients every day.Source: earnings call transcript | 65KI also want to thank our 65,000 associates who serve our members and patients every day.Source: earnings call transcript | 65KAnd finally, I want to thank our 65,000 associates who serve our members and patients every day.Source: earnings call transcript | 65KWith that, I would thank you for joining us this morning and for your interest in Humana, and I want to thank -- say thanks to our 65,000 associates who serve our members and our patients every day.Source: earnings call transcript | 65KAnd I also want to say thank you to our 65,000 associates who serve our members and our patients every day.Source: earnings call transcript | 65KAnd I also want to thank, as we always do, the 65,000 associates who make this place work, who serve our members, who serve our patients each and every day.Source: earnings call transcript | 0% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.